Manufacturer record
Janya Biocare Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Janya Biocare Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between June 2025 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: JIN25-028, Calcium Levulinate, Cholecalciferol & Cyanocobalmin Injetion Vet (exp Apr 2027). DTL Jaipur (state lab) found it not of standard quality: The sample does not conform to the IP with respect to Assay of Cholecalciferol. Listed in the January 2026 alert.
Records by type
3 records linked to Janya Biocare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium Levulinate, Cholecalciferol & Cyanocobalmin Injetion Vet | Batch JIN25-028Mfg May 2025 · Exp Apr 2027 | The sample does not conform to the IP with respect to Assay of Cholecalciferol.Assay | DTL JaipurState lab | Jan 2026 |
| Tramadol Hydrochloride and Acetaminophen Tablets (Paradol-T) | Batch JTN25-096Mfg Jun 2025 · Exp May 2027 | Test For DissolutionDissolution | NCT of DelhiState lab | Oct 2025 |
| Methylcobalamin 1500 mcg (Nuroark) | Batch JIN24-041Mfg Aug 2024 · Exp Jan 2026 | Description and Particulate MatterDescription | CDL KolkataCDSCO lab | Jun 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.